fibrinogen has been researched along with Biliary Tract Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Du, S; Jin, B; Ke, X; Lu, X; Mao, Y; Sang, X; Xu, H; Yang, H; You, W; Zhao, H; Zhong, S | 1 |
| Ji, X; Li, H; Liang, S; Wang, R; Wang, Z; Yang, Y; Yin, J; Zhao, T | 1 |
2 other study(ies) available for fibrinogen and Biliary Tract Cancer
| Article | Year |
|---|---|
Comprehensive analysis of coagulation indices for predicting survival in patients with biliary tract cancer.
Topics: Adult; Aged; Aged, 80 and over; Biliary Tract Neoplasms; Biomarkers, Tumor; Blood Coagulation; Blood Coagulation Tests; Female; Fibrinogen; Follow-Up Studies; Humans; Male; Middle Aged; Nomograms; Outcome Assessment, Health Care; Prognosis; Retrospective Studies; SEER Program; Survival Rate; Young Adult | 2021 |
Hyperfibrinogenemia predicts poor prognosis in patients with advanced biliary tract cancer.
Topics: Aged; Biliary Tract Neoplasms; Disease-Free Survival; Female; Fibrinogen; Humans; Male; Middle Aged; Neoplasm Staging; Prognosis; Retrospective Studies | 2016 |